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Abstract: Toxic blooms of cyanobacteria are ubiquitous in both freshwater and brackish 
water sources throughout the world. One class of cyanobacterial toxins, called 
microcystins, is cyclic peptides. In addition to ingestion and dermal, inhalation is a likely 
route of human exposure. A significant increase in reporting of minor symptoms, 
particularly respiratory symptoms was associated with exposure to higher levels of 
cyanobacteria during recreational activities. Algae cells, bacteria, and waterborne toxins 
can be aerosolized by a bubble-bursting process with a wind-driven white-capped wave 
mechanism. The purposes of this study were to: evaluate sampling and analysis techniques 
for microcystin aerosol, produce aerosol droplets containing microcystin in the laboratory, 
and deploy the sampling instruments in field studies. A high-volume impactor and an IOM 
filter sampler were tried first in the laboratory to collect droplets containing microcystins. 
Samples were extracted and analyzed for microcystin using an ELISA method. The 
laboratory study showed that cyanotoxins in water could be transferred to air via a bubble-
bursting process. The droplets containing microcystins showed a bimodal size distribution 
with the mass median aerodynamic diameter (MMAD) of 1.4 and 27.8 µm. The sampling 
and analysis methods were successfully used in a pilot field study to measure microcystin 
aerosol in situ.  Mar. Drugs 2007, 5                                    
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1. Introduction 
Cyanobacteria (blue-green algae) are ubiquitous in freshwater lakes, reservoirs, and brackish waters 
throughout the world (Carmichael, 1992; Oberholster et al. 2004). Under favorable conditions, certain 
cyanobacteria can form nuisance blooms or scums. Increased source water nutrient enrichment, or 
eutrophication, may contribute to the blue-green algae blooms (Chorus et al., 2000). These blooms can 
cause significant environmental impact due to decreased oxygen in the water, resulting in the die-off 
of fish and other organisms. Similar to marine algal blooms, some blue-green algal blooms can 
produce a spectrum of natural toxins, including hepatotoxins, neurotoxins, and dermatoxins (Codd et 
al., 1999). Toxic cyanobacteria blooms can cause acute poisoning to humans and animals.  
In the reported incidents of cyanobacteria poisoning in humans and livestock, microcystin is the 
most frequently cited cyanotoxin. Microcystins, which have several structural variants or congeners, 
are cyclic toxic peptides. Among approximately 65 variants of microcystin, the most common variant 
is microcystin-LR (MCYST-LR). These toxins can inhibit liver function and serine/threonine protein 
phosphatase enzymes. A survey of ponds and reservoirs found microcystin levels between 0.1 to 1000 
µg/L (Welker et al., 2005; Conti et al., 2005). Surface freshwater is being used as the primary source 
of drinking water for most of the world’s population, and the drinking water industry must remove 
contaminants before providing potable water to people. Public health agencies have proposed 
guidelines for safe levels of microcystin in water. The World Health Organization’s (WHO’s) 
recommended guidelines for drinking water limits the amount of microcystin to1 µg/L (WHO, 1998).  
A further component in the risk assessment of microcystin includes the evaluation of potential 
routes of exposure. In addition to ingestion and dermal, inhalation is included as a likely route of 
human exposure (Codd et al., 1999). Respiratory illness, including pneumonia, was reported in a 
number of people canoeing in freshwater reservoirs containing Microcystis blooms in the United 
Kingdom (Turner et al., 1990). Several epidemiological studies of human exposure to microcystins 
during recreational activities in fresh waters have been reported (Philipp et al., 1992; Pilotto et al., 
1997; Stewart et al., 2006). Reported health risks among people dinghy sailing in rivers with above 
normal levels of blue-green algae included minor morbidities such as upper respiratory and 
gastrointestinal symptoms as well as skin rash, ear pain, and eye irritation (Philipp et al., 1992). A 
prospective cohort study was conducted to investigate the incidence of self-reported symptoms in 
individuals exposed, through recreational activity, to cyanobacteria in lakes and rivers in Australia and 
the United States (Stewart et al., 2006). A significant increase in reporting minor symptoms, 
particularly respiratory symptoms, was associated with exposure to higher levels of cyanobacteria. A 
recommended limit ranging from 10 to 400 µg/L of microcystin has been suggested for the safe 
practice in managing recreational waters (Chorus et al., 1999). A corresponding group of potential 
health risks have been identified across this range of potential short-term exposure.  Mar. Drugs 2007, 5                                    
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Although aerosols are a potentially important source of exposure to blue-green algal toxins, 
increased respiratory symptoms are a major health risk when such exposure occurs. None of the 
anecdotal reports or epidemiological studies of exposure to cyanobacteria during recreational activities 
have indicated that air samples were taken to ascertain whether cyanotoxins can be airborne and cause 
these respiratory symptoms. Airborne algae cells, particularly blue-green algae at levels sometimes 
higher than pollens, were measured in several studies by McGovern et al. (1965) and Mittal et al. 
(1979). They also reported that many patients with nasobronchial allergies showed reactions to 
extracts of blue-green algae in skin tests. In addition, Bernstein and Safferman (1966) showed 
reduction of peak flow in skin-sensitized patients who were challenged with aerosols of green algae 
extracts.  
Algae cells, bacteria, and waterborne toxins can be aerosolized by a bubble-bursting process with a 
wind-driven white-capped wave mechanism (Blanchard and Syzdek 1972). When bubbles formed by 
trapped air rise to the water surface they burst and form jet drops and film drops (Blanchard and 
Syzdek 1975; Woolf et al., 1987. Algae and other microorganisms, which are concentrated in water 
surface films/forms, are ejected with and carried into the air by the droplets. This process is 
responsible for transferring salts, organic material, bacteria, and algae from water into the air 
(Blanchard and Woodcock 1957). One laboratory study has demonstrated the feasibility of aerosolized 
algae, including blue-green algae, by this bubble-bursting mechanism (Schlichting, 1974). Similarly, 
brevetoxins, products of marine algae, have been shown to be aerosolized in the laboratory by the 
same process (Pierce et al., 1989). Marine aerosols containing brevetoxins have been routinely 
sampled during red tide blooms in Florida (Pierce et al., 2002; Cheng et al., 2005a).  
In response to the need to monitor water sources relative to the proposed WHO drinking water 
guidelines, a number of techniques have been developed for the detection and quantification of 
microcystins. The standard for such analysis has been physicochemical methods, including liquid 
chromatography-mass spectrometry (LC/MS) analysis with accompanying sample preparation 
methods (Maizels and Budde, 2004). However several immunoassay techniques, including enzyme 
linked immunosorbent assay (ELISA) techniques have been developed and are commercially available 
(Chu et al., 1990; Fischer et al., 2001; Metcalf et al., 2001). 
Within the context of this background, the purposes of this study were to evaluate sampling and 
analysis techniques for microcystin aerosol, to produce aerosol droplets containing microcystin in the 
laboratory, and to deploy the sampling instruments in field studies. A commercially available ELISA 
kit was used for the detection and quantification of collected aerosolized microcystin. ELISA methods 
have been successfully applied when evaluating water samples and even human exposures via 
determining microcystin in human tissues (McDermott et al. 1995; Hilborn et al., 2005). The 
performance of a commercial ELISA kit was evaluated for sensitivity, reproducibility, and accuracy. 
The efficiency of extracting spiked microcystin from filter material used in the air sampling equipment 
was determined. The size distribution of microcystin aerosol generated from the bubble-bursting 
process was measured. Also included is a brief report on microcystin aerosol measurement in a pilot 
field study. These evaluations are key elements within the overall objective of assessing the inhalation 
exposure to microcystin aerosols in recreational or occupational settings. The results of the 
epidemiologic component of this field study are presented in Backer et al., in this issue. 
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2. Results and Discussion  
 
2.1. Filter Extraction Efficiency 
 
Extraction of known concentrations of MCYST-LR from glass fiber media yielded poor results. 
Four different concentrations of the microcystin solution were spiked on the glass filters. Spike 
recovery for all of the concentration levels was higher than the expected values. This may indicate a 
matrix effect interfering with qualification. However, the extraction efficiency of microcystin from the 
cellulose filter exhibited greater accuracy in measuring the expected values as shown in Table 1. The 
extraction efficiency for microcystin was nearly constant in the range of 0.1 to 5 ng on the filter. The 
mean extraction efficiency is 89.7% with a standard deviation (SD) of 11.1%. We proceeded to use 
cellulose filters for sample substrates for both high-volume and personal samplers.  
 
Table 1. Extraction efficiency for the cellulose filter. 
 
Spike mass 
(ng) 
Remaining 
vol. (µL) 
Extraction mass* 
(ng) 
Extraction efficiency* 
(%) 
5  800  5.53 ± 0.76  110.6 ± 15.2 
2.5  800  2.04 ± 0.18  81.6 ± 7.4 
1  800  0.83 ± 0.13  82.6 ± 12.7 
0.5  800  0.47 ± 0.10  93.1 ± 19.1 
0.25  800  0.22 ± 0.08  86.9 ± 30.5 
0.1  800  0.08 ± 0.02  82.8 ± 19.8 
     Mean 89.7 
     SD 11.1 
* mean ± SD    
 
A standard curve showing the ELISA response with MCYST-LR concentrations of 0.1 to 10000 
ng/L is shown in Figure 1. Also included in the figure is the response for the reading from the cellulose 
filter extraction when no MCYST-LR was added to the filter. The limit of detection (LOD) can be 
determined by the mean response of the minimum level of the standard measured plus three times the 
standard deviation. From Figure 1, an LOD of 70 ng/L was determined from the ELISA analysis. 
Assuming a sampling flow rate of 1.2 m
3/min and sampling time of 360 min, the LOD for the high-
volume impactor stage was 0.0014 ng/m
3. The LOD for the high-volume filter sample was 0.0037 
ng/m
3. Similarly, the LOD for the personal samplers was 0.090 ng/m
3 for a sampling flow rate of 10.6 
L/min and sampling time of 60 min.  
 
2.2. Particle Size Distribution and Concentration of Aerosolized Microcystins in the Laboratory 
 
Figure 2 shows a photo of bubbles generated from the glass dispersing tube with a pore size of 145 
to 174 µm. The bubble size is plotted in Figure 3 and shows a mean bubble size of 808 µm and Mar. Drugs 2007, 5                                    
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geometric standard deviation (GSD) of 1.19. Aerosol was produced in the laboratory using the same 
dispersion tube and a microcystin water concentration of 100 µg/L. This aerosol was collected in the 
high-volume impactor for 30 min at a flow rate of 300 L/min. Figure 4 shows the aerosol size 
distribution from averaging three filter cuts for each substrate filter. The figure shows a bimodal size 
distribution with the mass median aerodynamic diameter (MMAD) of 1.4 and 27.8 µm and the GSD of 
2.5 and 1.3 for the two peaks, respectively. The size distribution was taken from the freshly generated 
droplets. The droplets may undergo evaporation and sedimentation in the atmosphere and change their 
size, depending on the age of the droplets.  
 
Figure 1. Standard Curve of ELISA response as a function of MCYST-LR concentration. 
Concentration (ng/L)
0.1 1 10 100 1000 10000
A
n
s
o
r
b
a
n
c
e
 
(
B
/
B
o
)
0.2
0.4
0.6
0.8
1.0
1.2
 
 
 
 
Figure 2. Photo of bubbles produced using a glass dispersion tube. 
 
 
 Mar. Drugs 2007, 5                                    
 
 
141
Figure 3. Measured bubble size spectrum generated from a glass dispersion tube. 
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Figure 4. Aerosolized microcystins size distribution measured in the laboratory. 
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In a separate experiment, aerosol was generated from the same process to determine the microcystin 
concentration using the IOM personal sampler. The aerosol was generated using an aqueous 
concentration of 50 µg/L to get air concentrations around the LOD. Four personal samplers were 
deployed. Two samplers were placed at the center of the chamber while other samplers were at the 
sides. The aerosol was collected on these personal samplers for 60 min with a flow rate of 10.6 L/min. 
The calculated air concentration, corrected for a mean extraction efficiency of 0.897, was 0.20 ng/m
3 Mar. Drugs 2007, 5                                    
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and the SD was 0.06 ng/m
3. The measured concentration was slightly higher than the LOD (0.09 
ng/m
3).  
The laboratory study shows that cyanotoxins (including microcystins) in water can be transferred to 
air via a bubble-bursting process. The size spectrum of the bubbles used in our experimental apparatus 
was similar to the bubble size spectrum observed from breaking waves in a simulation wave tank 
(Blanchard and Woodcock 1957; Monahan and Zietlow, 1969). The droplet sizes between 0.1 to 50 
μm were similar to what have been measured in the simulated wave tank (Woolf et al., 1987) and 
likely represent the initial droplet size.  
This bubble-bursting process is responsible for the transfer of large quantities of salt, bacteria, 
algae, and dissolved chemicals from the marine environment to the atmosphere. It is also the process 
whereby red tide toxins (brevetoxins) generated from marine algae are transferred to the aerosol form. 
Inhalation of marine red tide aerosol has been found to be the main cause of respiratory symptoms in 
humans during occupational and recreational exposure (Backer et al., 2005; Fleming et al. 2005). 
Similarly, inhalation of aerosol containing microcystin may be responsible for respiratory symptoms 
reported by people participating recreational activities in fresh water containing blue-green algae. 
 
2.3. Field Study 
 
The weather conditions during the 8/4/2006 through 8/6/2006 field study are shown in Table 2. The 
temperature was relatively stable during the sampling. The average wind speeds were around 3.2 to 3.4 
m/s on 8/4 and 8/6 but lower (1.5 m/s) on 8/5.  
 
Table 2. Weather conditions in Bear Lake during the daytime sampling period. 
 
Date 
Temperature 
(C) 
Humidity  
(%) 
Average Wind Speed 
(m/s) 
8/4/2006  31.1 ± 1.4  38.4 ± 8.4  3.4± 0.9 
8/5/2006  29.7 ± 2.7  46.3 ± 8.0  1.5± 1.1 
8/6/2006  26. 0± 2.3  71.7 ± 10.0  3.2± 1.6 
 
One high-volume filter and one impactor sample were obtained each day. All three high-volume 
filter samples showed microcystin levels below the LOD (0.0037 ng/m
3). The high-volume impactor 
samples showed very low but detectable levels of 0.05, 0.023, and 0.057 ng/m
3 for 8/4, 8/5, and 8/6, 
respectively. Concentration levels at each impactor stage on 8/5 were barely above the LOD. Samples 
taken on 8/4 and 8/6 were used to determine the particle size distribution as shown in Figure 5A and 
5B. Figure 5A shows a bimodal particle size distribution with a fine particle mode at 0.4 μm and a 
coarse particle mode around 6.5 µm. Figure 5B shows a particle size with a mode around 0.5 μm and a 
lower concentration of coarse particles between 2 to 20 μm.  
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Figure 5. Microcystin particles size distribution obtained in Bear Lake, MI on 
8/4/2006 (A) and 8/6/2006 (B).  
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Personal samplers worn by volunteers recreating on the lake were analyzed for microcystin levels. 
The mean sampling duration varies from 60 to 200 min. One out of 10 personal samples obtained on 
8/4 and 4 out of 10 samples obtained on 8/5 were below the LOD. All four samples taken on 8/6 were 
below the LOD. Table 3 lists the sample number and measured aerosol concentration on 8/4, 8/5, and 
8/6.  
 
Table 3. Microcystin concentrations in personal samples. 
Date 
Microcystin Concentration 
(ng/m
3) Sample  Number 
8/4/2006  0.08 ± 0.09  10 
8/5/2006  0.07 ± 0.14  10 
8/6/2006  0.0 ± 0.0  4 
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The particle size distribution in the laboratory experiments showed a bimodal size distribution with 
a coarse particle mode around 20 to 30 µm and a fine particle mode around 1 to 3 µm. These two size 
modes may represent the jet drops and film drops, respectively. In the field study we also showed a 
distinguished bi-modal size distribution for aerosol collected on 8/4. The two size modes were 6.5 and 
0.4 µm, respectively. The size distribution obtained on 8/6 had a similar range but did not show a bi-
modal distribution.  
Assuming the droplets generated in the laboratory represent initial droplets from the bubble-
bursting process, the particle size distribution may change as the droplets evaporate. The droplet’s 
lifetime is a function of temperature, humidity, and droplet size. For micrometer-sized water droplets 
the calculated lifetime is less than a second (Hinds, 1999). When a droplet is dried, the particle size is 
reduced. The final particle size is dependent on the concentration of dissolved material and impurity in 
the water. This can be calculated as dp = C
1/3 dd, where C is the concentration of dissolved material and 
impurity; and dp and dd are particle diameter and initial droplet diameter, respectively. If we assume 
the droplet size distribution (Figure 4) was the initial particle size distribution and the concentration of 
dissolved material and impurity in Bear Lake was 1%, then the final particle size distribution can be 
calculated and shown in Figure 6. The final particle size also showed two size modes at 6.06 and 0.30 
µm respectively, which is in similar size range to the microcystin aerosol (Figure 5A) obtained at Bear 
Lake. This calculation illustrates a potential aerosol generation process for microcystin aerosol.  
 
 
Figure 6. Microcystin particle size distributions for impactor samples obtained in Bear 
Lake, MI on 8/4/2006 (A).  
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3. Conclusion 
 
We developed a sampling technique to obtain airborne microcystins in the laboratory and at a pilot 
field study. The high-volume samplers collect large volumes of air and thus have a lower LOD 
whereas the personal samplers have a higher LOD because of low sampling flow rates. The high-
volume cascade impactor also provided information on particle size distribution, which is an important 
parameter in estimating the inhaled dose. The commercial ELISA kits used standards of MCYST-LR 
for calibration, thus all concentrations were reported in nanograms of MCYST-LR per cubic meter of 
air. The ELISA analysis did not differentiate the chemical forms of cyanotoxins. Additional techniques 
such as high-performance liquid chromatography (HPLC) or LC/MS would be needed. The standard 
curves were slightly different each time when we analyzed our samples using ELISA standards. As 
recommended by the manufacturer’s instructions, a standard curve was determined for each analysis. 
For each individual standard regression, the r
2 value varied between 0.94 and 0.99, indicating some 
variability. This variability is typical of ELISA analysis and affects its accuracy and precision. For 
more accurate microcystin analysis, the HPCL or LC/MS method may be required. However, the 
ELISA technique is acceptable for analyzing microcystin aerosol samples. 
Our experiments showed that glass fiber is not an optimal substrate for analyzing microcystin using 
the ELISA method. Cellulose filters, on the other hand, showed very good extraction efficiency with a 
mean efficiency near 90%. The SD for the high concentration spike was below 20% and increased to a 
maximum of 30% for the low concentration spike.  
The laboratory study shows that cyanotoxin in water can be transferred to air via a bubble-bursting 
process. The droplets containing microcystins showed a bimodal size distribution with the MMAD of 
1.4 and 27.8 µm.  
The techniques were used in a pilot study to determine if aerosols containing microcystin could be 
found in fresh water with a blue-green algae bloom and if people engaging in recreational activity in 
the area could be exposed to the aerosol. The preliminary results show positive answers to both 
questions. Because of low levels of the microcystin (around 1 µg/L) in the water, the aerosol samples 
contained very low levels of microcystin barely above the LOD. In fact, over half of the personal 
samples contained a microcystin concentration below LOD. This field study demonstrated that we can 
detect very low levels of microcystin aerosol in areas with blue-green algae. Both high-volume and 
personal samplers show microcystin concentrations between 0.02 to 0.08 ng/m
3. This confirmed our 
laboratory results. In future studies of recreational exposure to blue-green algae blooms, aerosol 
characterization can provide useful information for determining the exposure and dose of inhaled 
microcystin.  
 
4. Materials and Methods 
 
4.1. Aerosol Sampling Equipment 
 
Aerosol sampling equipment used to collect red tide aerosol containing brevetoxins produced by 
Karenia brevis were used in this study (Cheng et al., 2005a,b,c). High-volume samplers (Model 
G2000H, Andersen Instruments, Smyrna, GA) were used to collect large quantities of aerosol material Mar. Drugs 2007, 5                                    
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for identification and quantization of microcystin. These samplers can house filters for collecting the 
total particulate sample. Alternatively a five-stage, high-volume cascade impactor (Model SA235, 
Andersen Instruments) can be placed inside the housing of a high-volume sampler. The impactor stage 
consists of rectangular slot jets. The air moves toward a collecting plate, then the flow makes a 90-
degree turn to go to the next stage. Particles are accelerated through the jet; particles with aerodynamic 
diameters larger than a specified cutoff diameter will not be able to follow the air flow because of 
inertia and will be collected in the plate. Smaller particles can follow the flow to the lower stage. A 
smaller nozzle size in the lower stages is designed to collect smaller particles. The sampler can be 
operated at a flow rate between 300 to 1000 L/min. At 566 L min
-1, the impactor has 50% cutoff 
aerodynamic diameters of 10.2, 4.2, 2.1, 1.4, and 0.73 µm. Six filter substrates were used to collect the 
six size-classified samples. Cellulose filters (15 cm x 14 cm) (Filter Paper 41, Whatman International 
Ltd., Maidstone, UK) were used as substrates.  
Personal exposure levels of human subjects in epidemiological studies were assessed by individuals 
wearing personal sampler (IOM Inhalable Dust Sampler, SKC Inc., Eighty Four, PA) connected to a 
battery-operated pump (Leland Legacy pump, SKC Instruments). The sampler was placed at the lapel 
near the breathing zone. The IOM Inhalable Sampler is designed to collect particles that are hazardous 
when deposited anywhere in the respiratory tract and follows the definition of inhalable particulate 
matter (Mark and Vincent, 1986; Phalen et al., 1986). Twenty-five-milliliter cellulose filters or glass 
filters (Type A/E, Gelman Sciences, Ann Arbor, MI) were tested as the collection substrate. The 
sampling flow rate of 10.6 L min
-1 was checked with a DryCal Flow Calibrator (BIOS International, 
Pompton Plains, NJ). 
 
4.2. Analysis of Microcystin 
 
Filter substrates used in the high-volume sampler and personal samplers were extracted for analysis 
via an ELISA method. ELISA kits for MCYST-LR were purchased from Abraxis (Production 
#520011, Abraxis LLC, Warminster, PA). The kits included a microtiter plate coated with an analog of 
microcystins conjugated to a protein, the standards (0, 150, 400, 1000, 5000 ppt), the antibody 
solution, the anti-sheep-HRP conjugate, the wash solution, the color solution, and the stop solution. 
The procedures suggested by the manufacturer were followed.  
The extraction efficiency of filter samples was determined as follows. One-hundred microliters of a 
defined MCYST-LR (CyanoHAB Services, Wright State University, MI) concentration was spiked on 
either a 25-mm cellulose (Whatman 41, Whatman International Ltd.) or glass-fiber (Whatman 
EPM2000, Whatman International Ltd.) filter. The extraction efficiency of both filter materials was 
experimentally determined. The filter was put into a glass vial, and 1 mL of phosphate buffer solution 
(PBS) was added. The vial was vortexed (Digital Vortex Mixer, Fisher Scientific, Denver, CO) for 30 
s, and placed on a circular rotator (Roto-Torque
® Low Speed #10; Cole-Parmer Instruments, Vernon 
Hills, IL) for 10 min. After rotation, the filter was removed from the extraction tube and the extract 
was used for ELISA analysis of microcystin. Before analysis, the final volume of the remaining 
extraction solution was measured to account for solvent that was absorbed by the filter.  
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4.3. Aerosolization of Microcystin 
 
Droplets of microcystin were generated in the laboratory using an aqueous solution by bubble-
bursting process. The experimental apparatus included a glass beaker placed inside a plastic tank as 
shown in Figure 7. The solution with microcystin concentrations of 50 and 100 µg/L was placed into 
the beaker. A glass dispersing tube with a pore size of 145 to 174 µm was placed in the beaker and 
connected to the compressed air hose with an airflow rate of 0.2 L/min to generate bubbles. The 
bubbles burst open and droplets were produced as they reached the surface of the solution. A high-
volume cascade impactor (Model SA235; Andersen Instruments), was used in this study to measure 
the aerosol size distribution.  
 
Figure 7. Experimental set-up for aerosolization of microcystin and impactor sampling device. 
 
Blower motor
Glass dispersion tube
(porosity A)
0.2 LPM compressed air
Lab Jack
Hi-Vol Impactor
 
 
 
Personal samplers (IOM Inhalable Dust Sampler; SKC, Inc.) were used to determine the minimum 
concentration of aerosolized waterborne microcystins that could be detected. The sampling flow rates 
for the high-volume impactor and the personal sampler were 300 L/min and 10.6 L/min, respectively. 
Water samples were taken before and after the test. Each impactor filter was cut into three small pieces 
(one from the top, one from the bottom, and one from the middle) for analysis after the test.  
 
4.4. Field Study 
 
A pilot field study was conducted to assess the exposure levels of people at risk for swallowing 
water or inhaling spray during recreational activities (water skiing, jet skiing, and boating) during a 
Microcystis aeruginosa bloom in a small recreational lake in Michigan on August 4 to August 6, 2006. 
Detailed experimental design and results were reported by Backer et al. (this issue). Here, we briefly Mar. Drugs 2007, 5                                    
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describe the aerosol sampling and monitoring of weather conditions. Two high-volume air samplers, 
each including a filter sample or a cascade impactor (Model SA235; Andersen Instruments), were 
placed on a motor boat that circulated in the lake to collect aerosol samples in the area. Personal 
samplers (IOM Inhalable Dust Sampler; SKC, Inc) were worn by human volunteers recreating on the 
lake to assess personal exposure levels. The sampling flow rates for the high-volume impactor and the 
personal sampler were 1170 L/min and 10.6 L/min, respectively. Cellulose filters as tested in our 
laboratory were used as the collection substrates. The high-volume samples were then cut into three 
pieces of about 12 cm
2 for analysis. Larger pieces were needed because of low aerosol concentration.  
A portable, solar-powered weather station was deployed on the Bear Lake waterfront near the 
impactor sampler to provide wind speed and direction, temperature, and relative humidity (Complete 
Weather Station, Davis Instruments, Hayward, CA). It continued to monitor weather conditions during 
the sampling period and the data were downloaded daily. The wind direction was measured at Bear 
Lake in 16 quadrants.  
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